| abstract |
A pharmaceutical composition comprising an agent for lowering statin and aspirin cholesterol in a formulation designed to minimize statin: aspirin interaction, in which: (i) the agent for lowering statin cholesterol and aspirin are formulated in a single bilayer tablet and in which aspirin is present in a first layer, and the statin cholesterol lowering agent is present in a second layer; or (ii) the pharmaceutical composition is in the form of a capsule containing both aspirin granules and granules of the statin cholesterol lowering agent. |